07:00 , Sep 23, 2013 |  BC Week In Review  |  Financial News

Benu BioPharma Inc. financial update

Management and consulting company Benu BioPharma launched its Benu BioVentures fund to establish virtual companies that will develop preclinical programs and move them to Phase II proof of concept. Benu said it has a single...
01:04 , Sep 17, 2013 |  BC Extra  |  Financial News

Benu BioVentures launches fund to back virtual companies

Management and consulting company Benu BioPharma Inc. (Natick, Mass.) launched its Benu BioVentures fund to establish virtual companies that will develop preclinical programs and move them to Phase II proof of concept. Benu said it...
07:00 , Jun 7, 2010 |  BioCentury  |  Emerging Company Profile

LipimetiX: Aping APOE

LipimetiX LLC is hoping to bypass defective LDL receptors in the livers of patients with heritable hyperlipidemia with its mimetics of apolipoprotein E , a protein that can target two additional hepatic receptors capable of...
07:00 , May 10, 2010 |  BC Week In Review  |  Company News

Benu Biopharma Inc., Exponential Pharma Ventures LLC deal

Benu Biopharma and Exponential Pharma Ventures formed a new virtual company called LipimetiX LLC to develop apolipoprotein E (APOE) mimetics. The newco's lead compounds, AEM-18 and AEM-28 , are in preclinical development to treat refractory...